Biomarkers in Cancer Staging, Prognosis and Treatment Selection
The p53 Tumor Suppressor Network Is a Key Responder to Microenvironmental Components of Chronic Inflammatory Stress
Molecular Interaction Maps of Bioregulatory Networks:
A General Rubric for Systems Biology
Nova regulates brain-specific splicing to shape the ynapse
High-Throughput GoMiner, an 'industrial-strength' integrative Gene Ontology tool for interpretation of multiple-microarray experiments, with application to studies of Common Variable Immune Deficiency (CVID)
Quality assessment of microarrays: Visualization of spatial artifacts and quantitation of regional biases
Three microarray platforms: an analysis of their concordance in profiling gene expression
Workshop on Cancer Biometrics: Identifying Biomarkers and Surrogates of Cancer in Patients: A Meeting Held at the Masur Auditorium, National Institutes of Health.
Karyotypic "state" as a potential determinant for anticancer drug discovery
Identification of non-cross-resistant platinum compounds with novel cytotoxicity profiles using the NCI anticancer drug screen and clustered image map visualizations
This web site is a development of the Genomics and Pharmacology Facility, Developmental Therapeutics Branch (DTB), Center for Cancer Research (CCR), National Cancer Institute (NCI).